InflaRx NV Net Worth
InflaRx NV Net Worth Breakdown | IFRX |
InflaRx NV Net Worth Analysis
InflaRx NV's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including InflaRx NV's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of InflaRx NV's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform InflaRx NV's net worth analysis. One common approach is to calculate InflaRx NV's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares InflaRx NV's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing InflaRx NV's net worth. This approach calculates the present value of InflaRx NV's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of InflaRx NV's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate InflaRx NV's net worth. This involves comparing InflaRx NV's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into InflaRx NV's net worth relative to its peers.
Enterprise Value |
|
To determine if InflaRx NV is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding InflaRx NV's net worth research are outlined below:
| InflaRx NV appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 63.09 K. Net Loss for the year was (42.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InflaRx NV currently holds about 23.68 M in cash with (37.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| InflaRx NV has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: InflaRx Trading Up 3.8 percent - Heres Why - MarketBeat |
InflaRx NV uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in InflaRx NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to InflaRx NV's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know InflaRx NV's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as InflaRx NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading InflaRx NV backward and forwards among themselves. InflaRx NV's institutional investor refers to the entity that pools money to purchase InflaRx NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Birchview Capital, Lp | 2024-09-30 | 50 K | Geode Capital Management, Llc | 2024-09-30 | 36.2 K | Northern Trust Corp | 2024-09-30 | 32.8 K | Two Sigma Investments Llc | 2024-09-30 | 24 K | Bnp Paribas Arbitrage, Sa | 2024-09-30 | 23.3 K | Citadel Advisors Llc | 2024-09-30 | 22.9 K | Pacifica Partners Inc | 2024-09-30 | 20.6 K | Engineers Gate Manager Lp | 2024-09-30 | 19.8 K | Schonfeld Strategic Advisors Llc | 2024-09-30 | 18.1 K | Suvretta Capital Management, Llc | 2024-09-30 | 5.7 M | 683 Capital Management Llc | 2024-09-30 | 2.1 M |
Follow InflaRx NV's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 138.96 M.Market Cap |
|
Project InflaRx NV's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.36) | (0.37) | |
| Return On Capital Employed | (0.43) | (0.46) | |
| Return On Assets | (0.35) | (0.37) | |
| Return On Equity | (0.42) | (0.44) |
When accessing InflaRx NV's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures InflaRx NV's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of InflaRx NV's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in InflaRx NV's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of InflaRx NV. Check InflaRx NV's Beneish M Score to see the likelihood of InflaRx NV's management manipulating its earnings.
Evaluate InflaRx NV's management efficiency
InflaRx NV has return on total asset (ROA) of (0.2198) % which means that it has lost $0.2198 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4534) %, meaning that it created substantial loss on money invested by shareholders. InflaRx NV's management efficiency ratios could be used to measure how well InflaRx NV manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.37 in 2024. Return On Capital Employed is likely to drop to -0.46 in 2024. At this time, InflaRx NV's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 4.3 M in 2024, whereas Total Assets are likely to drop slightly above 106.8 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.87 | 3.70 | |
| Tangible Book Value Per Share | 1.87 | 3.70 | |
| Enterprise Value Over EBITDA | (1.55) | (1.63) | |
| Price Book Value Ratio | 0.79 | 0.83 | |
| Enterprise Value Multiple | (1.55) | (1.63) | |
| Price Fair Value | 0.79 | 0.83 | |
| Enterprise Value | 69.4 M | 65.9 M |
The strategic initiatives led by InflaRx NV's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 449.2534 | Revenue 105.5 K | Revenue Per Share 0.002 | Return On Equity (0.45) |
InflaRx NV Corporate Filings
6K | 15th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
InflaRx NV Earnings per Share Projection vs Actual
InflaRx NV Corporate Management
| Jan CFA | Head VP | Profile | |
| Thomas Taapken | Chief Officer | Profile | |
| Derval OCarroll | Senior Compliance | Profile | |
| Igor Orshanskiy | Senior Development | Profile | |
| Maria Habel | Head RD | Profile | |
| Christian Schmid | VP Counsel | Profile | |
| Kofi Boaten | Senior Supplies | Profile |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.